Research Project · Health, Neuroscience, Neurodegenerative Disorders
The Treat FTD Fund
Alzheimer's Drug Discovery Foundationwww.alzdiscovery.org (opens in a new tab)Catalog updated
- Amount
- $2,500,000
- Program type
- Research Project
- Field
- Health, Neuroscience, Neurodegenerative Disorders
- Eligible career stages
- Not listed
About this program
The Treat FTD Fund, a joint initiative by the Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD), offers up to $2,500,000 over 1-3 years to support early-stage clinical trials focused on frontotemporal degeneration (FTD) disorders. Funding prioritizes phase 0, 1, or 2 trials, including disease-modifying and symptomatic approaches, with an emphasis on biomarker validation, patient-relevant outcomes, and innovative trial designs.
Eligibility is open to researchers and clinicians worldwide from academic medical centers, universities, non-profits, and biotechnology companies, including startups, with industry partnerships encouraged. Funding is provided through mission-related investments requiring return on investment based on scientific and/or business milestones.
In FundFit
Full eligibility
Source announcement
Similar programs
These details are in FundFit.